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Abstract: Prosthetic joint infection (PJI), although uncommon, is a dreaded and devastating
complication of total hip replacement (THR). Whether implant-related factors, such as the fixation
method, influences the risk of PJI following THR is contentious. We conducted a systematic review
and meta-analysis to evaluate the body of evidence linking fixation methods (cemented, uncemented,
hybrid, or reverse hybrid) with the risk of PJI following primary THR. Observational studies
and randomised controlled trials (RCTs) comparing fixation methods, and reporting PJI incidence
following THR, were identified through MEDLINE, Embase, Web of Science, Cochrane Library,
and reference lists of relevant studies up to 24 April 2019. Summary measures were relative risks (RRs)
(95% confidence intervals, CIs). We identified 22 eligible articles (based on 11 distinct observational
cohort studies comprising 2,260,428 THRs and 4 RCTs comprising 945 THRs). In pooled analyses
of observational studies, all cemented fixations (plain and antibiotic combined), plain cemented
fixations, hybrid fixations, and reverse hybrid fixations were each associated with an increased
overall PJI risk when compared with uncemented fixations: 1.10 (95% CI: 1.04–1.17), 1.50 (95% CI:
1.27–1.77), 1.49 (95% CI: 1.36–1.64), and 1.49 (95% CI: 1.14–1.95), respectively. However, in the first
six months, uncemented fixations were associated with increased PJI risk when compared to all
cemented fixations. Compared to antibiotic-loaded cemented fixations, plain cemented fixations were
associated with an increased PJI risk (1.52; 95% CI: 1.36–1.70). One RCT showed an increased PJI risk
comparing plain cemented fixations with antibiotic-loaded cemented fixations. Uncemented and
antibiotic-loaded cemented fixations remain options for the prevention of PJI in primary THR.
Keywords: fixation; antibiotic-loaded cement; uncemented; prosthetic joint infection; primary total
hip replacement; meta-analysis
1. Introduction
Total hip replacement (THR) is a highly successful and cost-effective orthopaedic intervention
for alleviating pain and disability associated with advanced joint disease such as osteoarthritis [1,2].
In 2017, over 100,000 THRs were performed in England, Wales, and North Ireland [3]. Although
the majority of patients undergoing THR experience marked improvements in pain and function [4],
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they are not without complications, which include aseptic loosening, dislocation, fracture, adverse
reaction to particulate debris, and prosthetic joint infections (PJIs) [3]. PJI is a devastating and dreaded
complication of THR [5] and can result in severe pain, functional deficits, poor quality of life, and even
death [6]. PJI management is also associated with high healthcare costs [7]. With increasing life
expectancy, increases in obesity, the growing healthcare burden of osteoarthritis, and a predicted
rise in the numbers of THRs, the number of patients who will be affected by PJIs will also rise
proportionately [8].
The risk of developing PJI is likely to be influenced by several factors, and these can be classified
into patient-related factors, surgery-related factors, and health system-related factors [9,10]. Whether
surgery-related or implant-related factors, such as the type of bearing and fixation method, influence
the risk of infection following THR has been the subject of debate in recent times [11]. In the most
recent published review of 11 randomised controlled trials (RCTs) and six observational studies, Hexter
and colleagues concluded there was no evidence to suggest that bearing choice influenced the risk of
PJI. Data on whether fixation methods affect PJI rates differentially following THR are controversial, as
previous findings have been inconsistent. Whereas some studies reported uncemented fixation was
associated with increased risk of revision because of infection compared to cemented fixation [12],
other studies reported opposite findings [13]. Hybrid fixation due to PJI has also been reported to be
associated with increased risk of revision compared to other fixation methods [14]. Authors of some of
these studies suggest findings might be due to the effect of biases such as residual confounding and
misdiagnosis of PJI [15]. In this context, we aimed to evaluate the body of evidence linking cemented,
uncemented, hybrid, and reverse hybrid fixation methods with the risk of PJI following primary
THR using a systematic review and meta-analysis of both observational and interventional evidence.
Our specific objectives were (i) to compare the nature and magnitude of potential associations of
different fixation methods with risk of PJI and (ii) to identify any gaps in the existing evidence.
2. Experimental Section
2.1. Data Sources and Search Strategy
We conducted this analysis in accordance with PRISMA and MOOSE guidelines [16,17],
(Supplementary Tables S1 and S2) using a predefined protocol which was registered with PROSPERO,
the International prospective register of systematic reviews (CRD42018106503). We systematically
searched MEDLINE, Embase, Web of Science, and Cochrane databases for studies comparing at least
two out of the main fixation types—cemented, uncemented, hybrid, and reverse hybrid—and reported
the incidence of PJI following primary THR. The search was restricted to human studies reported in
any language and included those published from the date of inception of each database to 24 April
2019. Full details of the search strategy are reported in Supplementary Table S3. The titles and abstracts
of all potentially relevant studies were initially screened to assess suitability for inclusion. Full texts
of articles potentially meeting eligibility criteria were then reviewed by two independent authors
(S.K.K. and A.D.B) for study selection. Disagreements regarding eligibility of an article were discussed
and consensus reached with involvement of a third author (M.R.W). The reference lists of relevant
retrieved articles were also manually scanned for all relevant additional studies and review articles
that were not identified by our original search.
2.2. Eligibility Criteria
Studies were included in our analyses if they were comparative observational studies or RCTs
that: (i) compared any two or more of the following fixation types: cemented, uncemented, hybrid,
and reverse hybrid fixation; and (ii) reported the incidence of PJI following primary THR. There were
no restrictions on the follow-up duration. We excluded studies in which the intervention was based on
only revision THR or resurfacing hip replacement.
J. Clin. Med. 2019, 8, 722 3 of 15
2.3. Data Extraction and Quality Assessment
Data extraction was conducted by one reviewer (S.K.K.) using a standardized data collection.
A second reviewer (A.D.B.) independently checked these data with those in the original articles.
We extracted data on study characteristics, interventions, and outcomes. In the case of multiple
publications involving the same cohort or study, the article with the most up-to-date or comprehensive
information was included. To assess the methodological quality of observational studies, we
used the nine-star Newcastle-Ottawa Scale (NOS) [18], a validated tool for assessing the quality
of nonrandomised studies. NOS measures the quality of evidence, from a score of zero to nine,
based on three predefined domains including: (i) selection of participants; (ii) comparability; and (iii)
ascertainment of outcomes of interest. A score of ≥5 indicated adequate quality for inclusion in our
review. For RCTs, we used Cochrane Collaboration’s risk of bias tool [19].
2.4. Data Synthesis and Analysis
Risk estimates expressed as relative risks (RRs) with 95% confidence intervals (CIs) were used as the
common measure of association across studies. Given PJI is a rare outcome, reported hazard ratios and
odds ratios were assumed to approximate the same measure of RR following Cornfield’s rare disease
outcome assumption [20]. Fully adjusted risk estimates were used if available, otherwise crude RRs
were estimated from studies that provided raw counts. Random-effect models were used to pool RRs
to minimize the effect of heterogeneity [21]. We reported estimates for the overall duration of follow-up
(long-term follow-up) and that for the early postoperative period (first six months of follow-up) for
studies that provided relevant data. Heterogeneity was assessed using the Cochrane χ2 statistic and
the I2 statistic [22]. We assessed for effect modification by predefined study-level characteristics such
as geographical location, population source (registry data vs. other cohorts), specific PJI outcome
(revision for PJI vs. infection), degree of adjustment (univariate vs. multivariate), and study quality
(high vs. low quality), using stratified analysis and random effect meta-regression [23]. Funnel plots
and Egger’s regression symmetry tests were used to assess publication bias. All statistical analyses
were based on two-sided tests with statistical significance defined as a p value < 0.05 and performed
with Stata release 15 (Stata Corp, College Station, Texas, USA).
3. Results
3.1. Study Identification and Selection
The literature search strategy identified 621 potentially relevant articles. After the initial screening
of titles and abstracts, 34 articles remained for full text evaluation. Following detailed evaluation
of full texts, 12 articles were excluded. The remaining 22 articles based on 11 distinct observational
cohort studies and 4 RCTs met the inclusion criteria and were included in the review (Figure 1;
Table 1) [10,12–14,24–41].
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Table 1. Characteristics of studies included in review.
Author, Year
of Publication
Year of
Study Country Indication for THR
Average Age
(Years)
Design, Source
of Data
Fixation Types
Compared
Average
Follow-Up
Duration, Years
No. of
Participants/Hips
Infection
Outcome
No. of
PJIs
Study
Quality
Wannske, 1979 NR Germany NK 63.7 RCT
Cemented with
antibiotics, cemented
without antibiotics
NK 476 Infection 15 NA
Wykman, 1991 1982–1984 Sweden
Osteoarthritis 77%,
rheumatoid arthritis
10%, other 13%
67.4/64.8 * RCT All cemented,uncemented Over 5.0 150 Infection 2 NA
Katz, 1992 1977–1987 Canada Avascular necrosis 63.0/54.0 *
Observational
cohort,
Consecutive case
series
All cemented,
uncemented 3.8 34 Infection 1 6
Laupacis,2002 1987–1992 Canada Osteoarthritis 64.0 RCT All cemented,uncemented 6.3 250 Infection 2 NA
Engesaeter,
2006 1987–2003 Norway
Primary
osteoarthritis 71.0
Observational
cohort, Registry
Uncemented,
cemented with or
without antibiotics
12.0 56,275 Revision dueto infection 252 8
Pospula, 2008 1994–2004 Kuwait Osteoarthritis 12.6%,other 87.4% 53.7/46.7 *
Observational
cohort,
Consecutive case
series
All cemented,
uncemented 5.0/3.0 182 Infection 5 6
Hooper, 2009 1999–2006 NewZealand All indications <55 to >75
Observational
cohort, Registry
All cemented, hybrid,
uncemented < and >90 days 42,665
Revision due
to infection 143 6
Dale, 2009 1987–2007 Norway
Osteoarthritis 72.2%,
inflammatory 3.7%,
other 24.1%
<40 to ≥80 Observationalcohort, Registry
Uncemented and
cemented with or
without antibiotics
5.0 97,344 Revision dueto infection 614 8
Pedersen, 2010 1995–2008 Denmark
Primary
osteoarthritis 78.4%,
others 21.6%
NR Observationalcohort, Registry
Hybrid, uncemented,
cemented with or
without antibiotics
4.6 80,756 Revision dueto infection 597 8
Hailer, 2010 1992–2007 Sweden
Primary
osteoarthritis 76%,
others 24%
<50 to >75 Observationalcohort, Registry
All cemented,
uncemented 5.8 170,413
Revision due
to infection 852 8
Dale, 2011 2005–2009 Norway NR NR Observationalcohort, Registry
All cemented,
uncemented, hybrid
1.0 (median,
29 days) 31,086
Revision due
to infection 236 8
Dale, 2011 2005–2009 Norway NR NR Observationalcohort, Registry
All cemented,
uncemented, hybrid
1.0 (median,
16 days) 5540 Infection 167 8
Kim, 2011 1991–1993 Korea Osteonecrosis 66%,others 34% 43.4/46.8 *
Observational
cohort,
Consecutive case
series
Hybrid, uncemented 18.4 219 Infection 4 7
Dale, 2012 1995–2009 NARA Osteoarthritis 80%,others 20% <40 to ≥90
Observational
cohort, Registry
Hybrid, all cemented,
reverse hybrid,
uncemented
5.0 432,168 Revision dueto infection 2778 8
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Table 1. Cont.
Author, Year
of Publication
Year of
Study Country Indication for THR
Average Age
(Years)
Design, Source
of Data
Fixation Types
Compared
Average
Follow-Up
Duration, Years
No. of
Participants/Hips
Infection
Outcome
No. of
PJIs
Study
Quality
Takenaga, 2012 1994–1999/1970–1976 USA
Osteoarthritis 11%
in cemented cohort,
39% in uncemented
cohort
42.0/40.1 * Observationalcohort
All cemented,
uncemented 18.0/12.0 * 208 Infection 4 6
Bolland, 2012 2003–2008 UK NR 64.7 Observationalcohort, Registry
All cemented, hybrid,
uncemented 3.0 220,399
Revision due
to infection 406 7
Makela, 2014 1995–2011 NARA
Primary
osteoarthritis 90.6%,
other 9.4%
55 and older Observationalcohort, Registry
All cemented, hybrid,
reverse hybrid,
uncemented
10.0 347,899 Revision dueto infection 877 6
Wyatt, 2014 NR NewZealand NR NR
Observational
cohort, Registry
All cemented, hybrid,
reverse hybrid,
uncemented
13.0 3319 Revision dueto infection 390 7
Schrama, 2015 1995–2010 NARA
Osteoarthritis 96.6%,
rheumatoid
arthritis 3.4%
68.8 Observationalcohort, Registry
Uncemented,
cemented with or
without antibiotics
16.0 390,671 Revision dueto infection 2315 8
Wangen, 2017 2000–2013 NARA Osteoarthritis 81%,others 20% 64.0/73.0 *
Observational
cohort, Registry
Reverse hybrid, all
cemented 3.3/6.2 * 496,567
Revision due
to infection 2309 8
Chammout,
2017 2009–2014 Sweden
Displaced femoral
neck fracture 73.0 RCT
Reverse hybrid, all
cemented 2.0 69 Infection 1 NA
Trela-Larsen,
2018 2003–2013 UK Osteoarthritis 63.7
Observational
cohort, Registry
Cemented with
antibiotics, cemented
without antibiotics
4.1 199,205 Revision dueto infection 595 8
Lenguerrand,
2018 2003–2013 UK
Osteoarthritis 93%,
others 7% 68.0
Observational
cohort, Registry
All cemented,
uncemented 4.6 623,253
Revision due
to infection 2705 8
NARA, Nordic Arthroplasty Register Association; NA, not applicable; NK, not known; NR, not reported; PJI, prosthetic joint infection; RCT, randomised controlled trial; THR, total hip
replacement; and *, exposure fixation type vs comparison fixation type.
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Figure 1. PRISMA flow diagram.
3.2. Study Characteristics and Study Quality
Table 1 provides key characteristics of relevant observational cohort studies and RCTs included in
the review. Overall, the studies involved about 2,260,428 THRs and 11,463 PJI cases. The majority of
observational studies were based on arthroplasty registries (6 out of 11) of Norway, Denmark, Sweden,
Finland, New Zealand and England, and Wales and Northern Ireland. The mean/median baseline age
of participants in the included studies ranged from 42 to about 75 years. Based on the overall data, most
uncemented THRs were performed in patients under 65 years of age, whereas cemented THRs were in
patients 65 years or older. PJI outcomes were reported in a variety of ways and included revision for
infection, deep infection, and surgical site infection; with registry studies reporting PJI outcomes as
revision because of infection, which was defined as removal or exchange of the whole or part of the
prosthesis, with deep infection reported as the cause of revision. The majority of included registry
studies did not specifically report how PJI was diagnosed. However, one of the included studies
indicated that reporting of infection as the cause of revision in registry studies reflected the surgeon’s
opinion based on clinical information and findings at surgery [39]. One registry study reported that
infection diagnosis was based on both the presence of preoperative clinical symptoms and the results
of microbiological culture from joint aspiration before surgery and/or during surgery [14]. The average
follow-up for PJI outcomes ranged from less than 3 months to 18 years. The methodological quality of
included observational studies ranged from six to eight.
Two of the RCTs were conducted in Sweden, one in Canada, and the other in Germany. Three of
the trials were published between 1979 to 2002, and one was a recent one published in 2017. The four
RCTs comprised 945 THRs and 21 PJI cases with sample sizes ranging from 69 to 476 THRs. The average
duration of follow-up for PJI outcomes ranged from 2 to 6.3 years. Using the Cochrane Collaboration
tool, two trials demonstrated a high risk of bias within one to two areas of study quality, which was
blinding of participants and personnel as well as outcome assessment. All trials had a low risk of bias
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in random sequence generation and incomplete outcome data, and they had an unclear risk of bias in
one or more areas of study quality (Supplementary Figure S1).
3.3. Fixation Types and Prosthetic Joint Infection (PJI) Risk
Figure 2 and Supplementary Figure S2 report RRs (95% CIs) for overall PJI comparing various
fixation types for included studies. In pooled analyses of 10 observational studies (1,308,868 THRs and
7281 PJIs), all cemented fixation (plain and antibiotic combined) was associated with an increased risk
of PJI when compared with uncemented fixation (1.10; 95% CI: 1.04–1.17). There was no significant
evidence of between-study heterogeneity (I2 = 39%; 95% CI: 0%–71%; p = 0.095). The results remained
the same on dropping studies in which THRs were performed in the 1970s and 1980s (1.10; 95% CI:
1.04–1.17). In a subgroup analysis, there was significant evidence of effect modification on the
comparison between all cemented and uncemented fixation by degree of covariate adjustment (p for
meta-regression = 0.03) and the study quality (p for meta-regression = 0.03). Though the associations
were significant and remained in the same direction, the RRs were stronger for univariate analyses
and studies of lower quality (Figure 3). In analysis limited to the first six months (three studies,
1,013,817 THRs, 3592 PJIs [10,29,35]), all cemented fixation was associated with a reduced risk of PJI
when compared with uncemented fixation (0.75; 95% CI: 0.63–0.89).
Compared with uncemented fixation, plain cemented fixation was associated with an increased
risk of PJI (1.50; 95% CI: 1.27–1.77). There was no significant difference in PJI risk when antibiotic-loaded
cemented fixation was compared with uncemented fixation (1.07; 95% CI: 0.97–1.18). Compared to
antibiotic-loaded cemented fixation, plain cemented fixation was associated with an increased PJI risk
(1.52; 95% CI: 1.36–1.70) (Figure 2; Supplementary Figure S3). In pooled analyses of six observational
studies (779,526 THRs and 4318 PJIs), hybrid fixation was associated with an increased risk of PJI
when compared with uncemented fixation (1.49; 95% CI: 1.36–1.64) (Figure 2; Supplementary Figure
S4). There was no evidence of significant heterogeneity between contributing studies (I2 = 53%; 95%
CI: 0%–81%; p = 0.06). When the postoperative period was limited to the first six months for the
comparison between hybrid and uncemented fixations (two studies, 390,564 THRs, 887 PJIs [29,35]),
the risk of PJI for hybrid fixation was 0.97 (95% CI: 0.75–1.25). Reverse hybrid fixations were associated
with an increased risk of PJI when compared with uncemented or all cemented fixations: 1.49 (95% CI:
1.14–1.95) and 1.18 (95% CI: 1.04–1.34) respectively (Figure 2; Supplementary Figure S5).
Figure 2. Fixation types and risk of prosthetic joint infection in observational and interventional studies.
CI, confidence interval (bars); PJI, prosthetic joint infection; and RR, relative risk.
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Figure 3. Comparison of all cemented fixation with uncemented fixation and the risk of prosthetic joint
infection in observational studies, grouped according to several study characteristics. CI, confidence
interval (bars); PJI, prosthetic joint infection; and RR, relative risk.
In RCTs, there were no differences in PJI risk when all cemented fixations were compared with
uncemented or reverse hybrid fixations; however, one trial conducted in the 1970s and based on 476
THRs and 15 PJIs, reported an increased PJI risk comparing plain cemented with antibiotic-loaded
cemented fixations (Figure 2; Supplementary Figure S6).
3.4. Publication Bias
A funnel plot for the analysis that involved ten studies (all cemented fixation vs. uncemented
fixation) was approximately symmetrical under visual examination (Supplementary Figure S7).
The results were consistent with Egger’s regression tests showing little evidence of publication bias
(p = 0.326).
4. Discussion
4.1. Key Findings
Given the uncertainty and controversy regarding the influence of fixation types on the incidence
of PJI following THR, we sought to evaluate the body of evidence linking cemented, uncemented,
hybrid, and reverse hybrid fixation methods with the risk of PJI following primary THR using a
comprehensive systematic review and meta-analysis of observational studies and RCTs. In pooled
overall analyses of observational studies, all cemented fixations, plain cemented fixations, hybrid
fixations, and reverse hybrid fixations were each associated with an increased overall PJI risk when
compared with uncemented fixations. However, for studies that reported data for the first six
postoperative months following THR, all cemented fixations were associated with a reduced risk of PJI
when compared with uncemented fixations. Further analysis on the risk of PJI, comparing all cemented
with uncemented fixations, showed that the relationship was modified by the degree of covariate
adjustment and the study quality. Plain cemented fixations compared to antibiotic-loaded cemented
fixations were associated with an increased PJI risk. When antibiotic-loaded cemented fixations were
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compared with uncemented fixations, there was no difference in PJI risk. Reverse hybrid fixations were
also associated with an increased PJI risk when compared with cemented fixations. Four relevant RCTs
were identified to have compared fixation types in relation to PJI, with one trial reporting increased PJI
rates when plain cemented fixations were compared with antibiotic-loaded cemented fixations.
4.2. Comparison with Previous Work
It was difficult to compare the current findings in the context of previous work, as we were
unable to locate previous reviews that evaluated the associations of the main fixation methods
(cemented, uncemented, hybrid, and reverse hybrid) with risk of PJI following THR. However, a recent
meta-analysis published by Yoon and colleagues compared PJI rates between all cemented and
uncemented fixations [42]. In a pooled analysis of six observational studies and two RCTs, all cemented
fixation was associated with a higher risk of PJI following THR compared with uncemented fixation.
Though these findings were consistent with some of our findings, our analysis was based on a larger
number of studies, and we have shown that the effects of all cemented and uncemented fixations
on PJI risk may vary according to the postoperative period following primary THR—all cemented
fixation being associated with a reduced PJI risk during the first six postoperative months. We also
conducted subgroup analysis by several relevant study-level characteristics. Given that infection rates
could be influenced by the presence or absence of antibiotics in the cement, we also compared PJI rates
between cemented fixations with (antibiotic-loaded) or without antibiotics (plain) using studies that
reported these data. There were attempts to do this in the previous review [42], but this investigation
was limited as the authors performed meta-regression analysis by year of publication based on the
assumption that later published studies used antibiotic-loaded cements. Another limitation of the
previous review was that the authors inappropriately performed pooled analysis of different study
designs (observational studies and RCTs). In a meta-analysis of nine RCTs comparing all cemented with
uncemented fixation in primary THR, Abdulkarim and colleagues reported no significant difference
in revision rates or mortality between the two fixation types [43]. However, cemented fixation was
associated with better short-term clinical outcomes such as improved pain score. The authors could
not compare infection rates, as these outcomes were not reported by the studies they included. Wang
and colleagues in a meta-analysis of eight RCTs compared the use of antibiotic-loaded cement with
plain cement or systemic antibiotics for the incidence of deep infection in primary THR or total knee
replacement [44]. In a subgroup analysis by type of joint replacement, antibiotic-loaded cement was
observed to significantly reduce deep infection rates in a pooled analysis of two trials of hip patients.
However, in one of these trials, the control group comprised patients who only received systemic
antibiotics and not plain cemented fixation.
4.3. Possible Explanations for Findings
A number of mechanisms may account for some of the associations demonstrated. The increased
risk of overall PJI associated with cemented prostheses compared with uncemented prostheses has been
attributed to bone necrosis caused by direct toxicity or generation of heat during the polymerization
process [45], which may create conditions conducive for bacterial growth [46]. Another potential
explanation is the longer duration of surgery for cemented THRs (compared with uncemented THRs),
hence an increased likelihood of perioperative contamination [27]. Antibiotic-loaded bone cement
fixations have a lower risk of infection compared with plain bone cement, which confirms a protective
effect of the elution of antibiotics from the bone cement. The protective effect of all cemented fixations
on PJI risk compared to uncemented fixations in the first six months most likely is due to the effects
of antibiotics in the bone cement during this period. The amount and duration of antibiotic release
from bone cement is still unclear and a widely debated topic [47,48]. The duration of antibiotic release
has been reported to last from a few hours to several weeks [47–49]. Though antibiotic elution from
bone cement decreases with time, this decrease is influenced by factors such as the type and amount of
antibiotics, cement type and porosity, and surface in contact with the liquid of the environment [50–54].
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Bone cements in greater contact with body fluids and with greater porosity have more sustained elution.
The increased risk of PJI associated with hybrid fixations (compared with uncemented fixations) is also
not clear, especially as a majority of these implants include cement with antibiotics [13]. Pedersen and
colleagues speculated that the included cement could be a source of microorganisms [13]. Whether age
influenced the relationship between fixation techniques and risk PJI in THR was uncertain, because
previous evidence has been inconsistent [29,31], and we were unable to evaluate this from our data.
However, cemented fixation has been the gold standard for older patients, whereas uncemented
fixation has commonly been used in younger patients. Hailer and colleagues in their report, which
stratified by different age groups, demonstrated that no particular age group benefitted more from
uncemented fixation [31]. It was also possible that the findings which were based on observational
data, may have been driven by study design limitations and other risk factors for PJI such as age, body
mass index, lifestyle factors, comorbidities, and perioperative effects, which were not accounted for in
some of the studies. Indeed, we showed that the relationship between some of the fixation types and
risk of PJI could be influenced by the extent of covariate adjustment as well as the methodological
quality of the studies.
4.4. Implications of Our Findings
PJI incidence is expected to rise given the growing burden of osteoarthritis and the large increase
in the numbers of THRs being performed worldwide [8]. Prosthesis design and materials are constantly
evolving. To date, there is no consensus among surgeons regarding the ideal fixation method because
of surgical preferences and inconsistent evidence in the literature. Cemented THR used to be the
gold standard, but its use has declined in favour of uncemented prostheses, which are now the most
common types used for THR globally [55]. However, there have been concerns that uncemented
fixations do not improve health outcomes sufficiently to justify their high costs [56]. Though a
number of studies have reported cemented fixations to be associated with high failure rates, deep
vein thrombosis, heterotopic ossification, and PJI [13,29,55], the evidence in favour of uncemented
fixation is also not very strong, as it has been linked to high revision rates and increased risk of
periprosthetic fracture [14,35]. Proponents of uncemented fixation list advantages such as reduced risk
of cement-related cardiovascular and thromboembolic complications, shorter surgical time, a wider
range of bearing surface options, possibility of biological fixation, and easier prosthesis removal in case
of a need for revision [55] in addition to a lower risk of PJI. Cemented fixations are reported to offer
better integration between bone, cement, and prosthesis, thereby providing immediate postoperative
benefits in terms of pain relief and earlier weight-bearing status. Though existing evidence has been
uncertain, the current findings based mainly on observational data suggest that uncemented fixations
are generally associated with a lower PJI risk compared to other fixation types in the long-term. Limited
data based on observational and interventional evidence showed that antibiotic-loaded cemented
fixations when compared with plain cemented fixations were associated with a lower PJI risk. We have
also shown there were only few trials published that actually compared PJI rates between fixation
types. The majority of these trials, which were published over two decades ago, did not prespecify
PJI as the primary outcome, and if reported, there were only a small number of events. Nevertheless,
based on currently available data, uncemented fixations appear to be associated with lower PJI risk
when compared to other fixation types, and antibiotic-loaded cemented fixations are also associated
with a lower PJI risk when compared with plain cemented fixations. However, in the first six months
following THR, uncemented fixations appear to be associated with increased PJI risk when compared
with all cemented fixations. Furthermore, results suggest that uncemented fixations may be as effective
as antibiotic-loaded cemented fixations in preventing PJI, but further data are needed. This evidence
should be considered by surgeons when selecting fixation methods for THR, particularly in those
at high risk of infection such as males with comorbidities [9]. Ultimately, RCTs will be best placed
to address uncertainties in the evidence, but those published so far were conducted several decades
ago, were underpowered, and PJI was not always their primary outcome. An appropriate definitive
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RCT using PJI as the primary outcome is unlikely in the short term; it would require a sample size
of between 6650–13,348 patients per arm with a 10-year follow-up [57]. A two-year follow-up RCT
would require a substantially larger sample. Despite RCTs being the gold standard for the design of
clinical research, their use in assessing the effectiveness of orthopaedic devices has several drawbacks.
They are labour intensive, expensive, and they have a late response given the demand for long-term
follow-up [58]. Furthermore, the use of strict inclusion and exclusion criteria for these study designs
make generalization of their findings to real world settings unreliable. Nesting analysis within
arthroplasty registries may represent a better investigative avenue if they contain adequate reporting
of infection outcomes.
4.5. Study Strengths and Limitations
To our knowledge, and based on the evidence available, this is the most comprehensive systematic
review and meta-analysis evaluating evidence linking cemented, uncemented, hybrid, and reverse
hybrid fixation methods with PJI risk following THR. In addition to strengths mentioned previously,
we employed a comprehensive search strategy across multiple databases, thereby identifying several
relevant studies conducted on the topic. We harmonized fixation comparisons across studies
(to a common reference) where possible, which ensured consistency and enhanced interpretation.
Based on detailed extraction of data, we were also able to report estimates for the early postoperative
period and assess effect modification using subgroup analysis. We also carried out assessment of
publication bias. Furthermore, we conducted a detailed quality assessment of all studies using
validated tools. There were some limitations to the current study that deserve mention. The lack of
reporting or the heterogeneous definition of PJI by included studies could have limited the validity of
the findings. Our analyses of time-specific effects of fixation types on PJI risk were limited because
only few studies reported these data. Given the limited number of studies for pooling (<10) for the
majority of comparisons, we were unable to adequately explore for other sources of heterogeneity.
There is a possibility that relevant characteristics, such as age differences, cement types, and differences
in bone cement antibiotics, could have introduced some biases in the pooled results. We were unable
to explore the effects of these in subgroup analyses, as these data were not available in the included
reports. We were careful not to double count patients given that some of the studies were based on
the same registry data and, therefore, presenting the possibility of patient overlap. Nevertheless,
there might be a small chance that some patients could have been double-counted. Other inherent
limitations to the review included the limited number of RCTs available and use of observational
study designs, which do not prove causation. Finally, given that some studies were conducted several
decades ago, inclusion of these data may not reflect current standards of practice, as fixation methods,
duration of surgery, as well as PJI rates have changed over time. We were unable to conduct a subgroup
analysis comparing the periods of surgery as the majority of studies reported data that spanned over
three decades. However, in the analysis that compared cemented fixation with uncemented fixation,
dropping data reported for THRs performed in the 1970s and 1980s did not change the results. Given
the limitations, these findings should be interpreted with caution. To address issues with employing
consistent definition of PJI outcomes in the analyses, time-specific effects of fixation types on PJI risk,
and accounting for relevant covariates such as age and assessment of heterogeneity, we also propose
an individual participant data meta-analysis of these studies [59].
5. Conclusions
Aggregate observational evidence suggests uncemented fixations are associated with lower
overall risk of PJI compared with other fixation types. The effects of uncemented and all cemented
fixations on PJI risk may vary in early postoperative periods. Limited observational and trial data
show antibiotic-loaded cemented fixations are also associated with a lower PJI risk when compared
with plain cemented fixations.
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